Addiction in context. Single-case experimental design study about the added value of VR in cognitive behavioural therapy for people with intellectual disability and substance use disorder.

• Conditions: verslavingsstoornis (stoornis in het gebruik van middelen); Substance Use Disorder; Addiction

• Registration Number: NL-OMON56932
• Lead Sponsor: niversiteit Twente

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

Participants will be included in the study when:
- They voluntary want to participate in the study and can give informed consent
- They are 18 years or older
- Follow a CBT program, such as *Minder Drank of Drugs*, for individuals with
mild Intellectual Disability (ID) or Borderline Intellectual Functioning (BIF),
and SUD.
- They have a sufficient understanding of the Dutch language and are able to
answer simple questionnaires, whether or not with some extra help of the
researcher / therapist
- They are in possession of a smartphone on which they can (either
independently or with some help) download the experience sampling app

Exclusion Criteria

- If there are any conditions that precludes potential participants from
participating in an outpatient CBT+ program (e.g. severe current psychiatric
co-morbidities)
- If clients have a known history of epilepsy or severe motion sickness, or
show signs of severe motion sickness during the VR try-out.
- If clients are under the supervision of a legal custodian or mentor and are
unable to provide informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Virtual Reality can potentially lead to a better understanding of one's risk<br /><br>situations and triggers, and the generalization of coping strategies to daily<br /><br>life. This is assumed to increase client's self-efficacy in coping with their<br /><br>substance use disorder. Therefore, self-efficacy is measured as the primary<br /><br>outcome measure. </p><br>